Literature DB >> 17908830

Overactive bladder: treatment options in primary care medicine.

David O Sussman1.   

Abstract

Overactive bladder is a highly prevalent condition, affecting approximately 33 million adults in the United States. Despite the considerable impact this condition has on patients' quality of life, overactive bladder remains underrecognized and undertreated as a result of patient embarrassment and reluctance to seek medical help, as well as a lack of proactive questioning by physicians. The present article encourages physicians to initiate a dialogue with patients regarding urinary control and, specifically, overactive bladder. Treatment options for overactive bladder recommended in the current article include both nonpharmacologic and pharmacologic therapies. Properties of antimuscarinic agents, including three new drug therapies, are reviewed and provided for physicians to optimize therapy options, particularly among elderly patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17908830

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  3 in total

1.  A comparative review of oxybutynin chloride formulations: pharmacokinetics and therapeutic efficacy in overactive bladder.

Authors:  Michael J Kennelly
Journal:  Rev Urol       Date:  2010

2.  Effect of caffeine on bladder function in patients with overactive bladder symptoms.

Authors:  Supatra Lohsiriwat; Muthita Hirunsai; Bansithi Chaiyaprasithi
Journal:  Urol Ann       Date:  2011-01

Review 3.  Recent advances in pharmacological management of urinary incontinence.

Authors:  Bronagh McDonnell; Lori Ann Birder
Journal:  F1000Res       Date:  2017-12-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.